[Inflammatory cardiomyopathy and myocarditis]

Area of Science:

• Cardiology
• Pathology
• Medical Imaging

Background:

• Inflammatory cardiomyopathy and myocarditis require precise diagnosis and etiology assessment.
• European Society of Cardiology guidelines provide a framework for management.
• Recent advancements offer new diagnostic and therapeutic strategies.

Purpose of the Study:

• To outline diagnostic and treatment approaches for inflammatory cardiomyopathy and myocarditis.
• To integrate etiological considerations into patient management.
• To highlight recent developments in the field based on ESC guidelines.

Main Methods:

• Review of a landmark position paper from the European Society of Cardiology's Working Group Myocardial and Pericardial Diseases.
• Incorporation of recent developments in diagnosis and treatment.
• Discussion of multimodality imaging and invasive diagnostic procedures.
• Histological and molecular analysis of endomyocardial biopsies.

Main Results:

• Diagnosis hinges on assessing etiology, clinical presentation, course, and prognosis.
• Endomyocardial biopsy with histological and molecular methods distinguishes viral from autoreactive myocarditis.
• This differentiation allows for individualized, targeted therapy.

Conclusions:

• Accurate etiological diagnosis is crucial for managing inflammatory cardiomyopathy and myocarditis.
• Distinguishing between viral and autoreactive forms guides personalized treatment strategies.
• Targeted therapies, informed by biopsy results, offer benefits beyond general heart failure management.